MISSION BIO INC

Single-cell Technology for Precision Medicine

SOUTH SAN FRANCISCO, United States · Founded 2015 · $110.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$110.0M
Last Round
$70.0M Series CAug 2020
Rounds
3

About

Mission Bio develops single-cell multi-omics technology for precision medicine and cancer research. Their Tapestri platform simultaneously measures single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. The company serves oncology researchers and pharmaceutical developers focused on hematologic malignancies, solid tumors, cell and gene therapy, and biomarker development.

Summary

MISSION BIO INC is a Biotech company based in SOUTH SAN FRANCISCO, United States, founded in 2015. It has raised $110.0M in total across 3 rounds, most recently a $70.0M Series C round in Aug 2020. Investors include Mayfield Fund, Novo Holdings A/S and Cota Capital.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries CAug 2020
$70.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies